XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Changes in Stockholders’ Deficit - USD ($)
Class A
Common Stock
Class B
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Feb. 18, 2021 [1]
Balance (in Shares) at Feb. 18, 2021 [1]      
Issuance of founders’ share $ 876 [1] 24,124 25,000
Issuance of founders’ share (in Shares) [1]   8,763,333      
Sale of 890,000 Private Placement Units $ 89 [1] 8,899,911 8,900,000
Sale of 890,000 Private Placement Units (in Shares) 890,000 [1]      
Initial classification of warrant, net of offering costs [1] 7,362,578 7,362,578
Net Income (Loss) [1] (99,988) (99,988)
Accretion of common stock subject to possible redemption [1] (16,286,613) (5,879,395) (22,166,008)
Balance at Dec. 31, 2021 $ 89 $ 876 [1] (5,979,383) (5,978,418)
Balance (in Shares) at Dec. 31, 2021 890,000 8,763,333 [1]      
Net Income (Loss) [1] 1,115,764 1,115,764
Forfeiture of Founder Shares $ (15) [1] 15
Forfeiture of Founder Shares (in Shares) [1]   (148,192)      
Sale of private placement units in over-allotment $ 9 [1] 860,801 860,810
Sale of private placement units in over-allotment (in Shares) 86,081 [1]      
Fair value of warrants in over-allotment [1] 454,360 454,360
Accretion of common stock subject to possible redemption [1] (1,315,176) (3,638,157) (4,953,333)
Balance at Dec. 31, 2022 $ 98 $ 861 [1] $ (8,501,776) $ (8,500,817)
Balance (in Shares) at Dec. 31, 2022 976,081 8,615,141 [1]      
[1] Includes up to 1,133,333 shares of Class B Common stock subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriter. The underwriter for the IPO partially exercised its over-allotment option on January 14, 2022 (see Note 7).